Alpine immune sciences, inc. (ALPN)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Net Income (Loss) Attributable to Parent

-41,852

-36,487

-7,783

-1,232

-22,818

-15,036

-

Net loss

-

-

-

-

-

-

-16,198

Adjustments to reconcile net loss to net cash used in operating activities:
Change in value of preferred stock warrant liabilities and derivative

-

-

-

-

-

-296

-9

Loss on sale of property and equipment

-16

0

0

-

-

-

-

Gain (Loss) on Disposition of Intangible Assets

0

-1,203

0

0

-

-

-

Bargain purchase gain

0

0

6,601

0

-

-

-

Depreciation and loss on disposal of assets

-

-

-

-

66

88

-

Depreciation expense

468

388

241

69

-

-

219

Amortization of premium/discount on investments

360

669

0

0

-

-

-

Non-cash interest expense

140

169

87

0

-

-

-

Deferred income tax

0

-305

-204

0

-

-

-

Stock-based compensation expense

3,041

2,309

838

77

1,343

70

98

Amortization of deferred financing costs and noncash interest

-

-

-

-

-

708

521

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

408

-66

1,193

26

-198

380

107

Right-of-use asset

1,553

0

-

-

-

-

-

Accounts payable and accrued liabilities

816

5,390

-226

-

-

-

-

Accounts payable

-

-

-

80

65

258

400

Deferred revenue

1,435

-480

-1,731

-2,950

-

-

-

Lease liabilities

-195

0

-

-

-

-

-

Accrued liabilities

-

-

-

39

-

-

-

Increase (Decrease) In Deferred Rent And Other Operating Liabilities

-

-

-

146

-

-

-

Accrued direct program expenses

-

-

-

-

311

355

540

Accrued employee benefits

-

-

-

-

1,465

-183

55

Accrued other liabilities

-

-

-

-

163

-32

-26

Net cash used in operating activities

-35,346

-28,416

-16,572

-3,797

-

-

-

Investing activities
Net cash used in operating activities

-

-

-

-

-19,207

-14,448

-14,293

Purchases of property and equipment

821

495

586

782

188

4

125

Proceeds from sale of intangible asset

0

250

0

0

-

-

-

Purchase of short-term investments

59,382

72,863

88,307

0

-

-

-

Maturities of short-term investments

75,575

105,226

0

-

-

-

-

Maturities of short-term investments

-

-

-

0

-

-

-

Proceeds from the sale of short-term investments

1,391

0

27,960

0

-

-

-

Cash and cash equivalents acquired in connection with merger

0

0

31,130

0

-

-

-

Purchase of short-term investments

-

-

-

-

76,260

-

-

Proceeds from sales and maturities of marketable securities

-

-

-

-

14,000

-

-

Net cash provided by investing activities

16,763

32,118

-29,803

-782

-

-

-

Financing activities
Proceeds from borrowings, net of issuance costs

1,977

0

5,000

0

-

-

-

Proceeds from Issuance of Convertible Preferred Stock

0

0

37,666

10,925

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-62,448

-4

-125

Proceeds from sale of common stock, net of offering costs

23,598

0

0

-

78,771

-

-

Proceeds from issuance of convertible preferred stock, net

-

-

-

-

-

29,935

-

Decrease in restricted cash

-

-

-

-

-

-2,500

-

Proceeds from notes payable, net

-

-

-

-

-

11,868

12,000

Repayment of debt

1,333

1,000

0

0

-

3,139

1,189

Proceeds from exercise of stock options

13

9

22

50

63

2

-

Net cash provided by financing activities

24,255

-991

42,688

10,975

-

-

-

Effect of exchange rate on cash, cash equivalents and restricted cash

-6

0

0

-

-

-

-

Net increase in cash and cash equivalents and restricted cash

5,666

2,711

-3,687

6,396

-

-

-

Net cash provided by financing activities

-

-

-

-

78,834

41,166

10,811

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-2,821

26,714

-3,607

Supplemental Information
Convertible preferred stock exchanged for common stock

0

0

49,201

0

41,880

-

-

Discount in connection with issuance of debt

0

0

428

0

-

-

-

Cash paid for interest

170

149

53

0

-

-

-

Recognition of right-of-use asset

11,173

0

-

-

-

-

-

Cash paid for income taxes

0

0

76

0

-

-

-

Cash paid for interest

-

-

-

-

-

165

124

Reclass of preferred stock warrant liability to equity

-

-

-

0

-

-

-

Conversion of convertible debt and accrued interest to convertible preferred stock, net

-

-

-

-

-

24,655

12,365